Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C viruses.
about
Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C viruses.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Seroprevalence of parvovirus B ...... iency and hepatitis C viruses.
@en
Seroprevalence of parvovirus B ...... iency and hepatitis C viruses.
@nl
type
label
Seroprevalence of parvovirus B ...... iency and hepatitis C viruses.
@en
Seroprevalence of parvovirus B ...... iency and hepatitis C viruses.
@nl
prefLabel
Seroprevalence of parvovirus B ...... iency and hepatitis C viruses.
@en
Seroprevalence of parvovirus B ...... iency and hepatitis C viruses.
@nl
P2093
P2860
P1433
P1476
Seroprevalence of parvovirus B ...... ciency and hepatitis C viruses
@en
P2093
P2860
P304
P356
10.1111/J.1365-2516.1995.TB00050.X
P577
1995-04-01T00:00:00Z